- Recent Funding
- Investors
- Wachstumsfonds Bayern
Wachstumsfonds Bayern portfolio
Wachstumsfonds Bayern has 1 portfolio company on record at Recent Funding. Its most recent investment on record is CatalYm's $59.04M Series B+ round in November 2020, alongside Vesalius Biocapital Partners, Novartis Venture Fund, Forbion Capital Partners and 2 others. That company is in Health and bio.
What Wachstumsfonds Bayern invests in
- Health and bio · 1 · 100%
How Wachstumsfonds Bayern invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $59.04M |
Share is of the 1 round on Recent Funding that name Wachstumsfonds Bayern. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Wachstumsfonds Bayern portfolio companies
| Company | Round with Wachstumsfonds Bayern | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $59.04M | $259.04M | Jul 16, 2024 Series B+ |
Most frequent co-investors
BBioGeneration Ventures1 shared round · last Nov 10, 2020
VVesalius Biocapital Partners1 shared round · last Nov 10, 2020
FForbion Capital Partners1 shared round · last Nov 10, 2020
NNovartis Venture Fund1 shared round · last Nov 10, 2020
- Ccoparion1 shared round · last Nov 10, 2020
Similar investors
AAccelia Capital1 company · 1 deal in 12 mo
AAngel Academe1 company · 1 deal in 12 mo
BBioGenerator Ventures1 company · 1 deal in 12 mo
BBiospring Partners1 company · 1 deal in 12 mo
CColossa Ventures1 company · 1 deal in 12 moFFirst Imagine!1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
Portfolio companies are the companies on Recent Funding with a round that lists Wachstumsfonds Bayern, which is a subset of its real portfolio. API: /api/v1/investors/wachstumsfonds-bayern (get a free API key). More: the most active VC firms and new venture capital funds.